Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab

Rheumatology (Oxford). 2014 Jul;53(7):1352-3. doi: 10.1093/rheumatology/keu019. Epub 2014 Mar 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Humans
  • Macrophage Activation Syndrome / drug therapy*
  • Macrophage Activation Syndrome / etiology*
  • Male
  • Myocarditis / drug therapy*
  • Myocarditis / etiology*
  • Still's Disease, Adult-Onset / complications*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • tocilizumab